Ignite Creation Date:
2025-12-24 @ 7:36 PM
Ignite Modification Date:
2025-12-29 @ 6:39 AM
Study NCT ID:
NCT04710303
Status:
COMPLETED
Last Update Posted:
2024-11-15
First Post:
2021-01-13
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
COVID-19 Vaccination Using a 2nd Generation (E1/E2B/E3-Deleted) Adenoviral Platform in Healthy South African Adults
Sponsor:
ImmunityBio, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-03-02
Start Date Type:
ACTUAL
Primary Completion Date:
2022-08-02
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-08-02
Completion Date Type:
ACTUAL
First Submit Date:
2021-01-13
First Submit QC Date:
None
Study First Post Date:
2021-01-14
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2024-04-04
Results First Submit QC Date:
None
Results First Post Date:
2024-11-15
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-09-10
Last Update Post Date:
2024-11-15
Last Update Post Date Type:
ACTUAL